Clinical Trial Update: A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) [Phase 1]

View source ↗

Summary

This update describes an ongoing Phase I clinical trial evaluating PET imaging with the radiotracer [18F] 4-L-Fluoroglutamine in patients with solid tumors and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• [18F] 4-L-Fluoroglutamine

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Malignancy, Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING